Reference
Secinaro E, et al. SGLT2-inhibitors and euglycemic diabetic ketoacidosis in COVID-19 pandemic era: a case report. Acta Diabetologica 59: 1391-1394, No. 10, 19 Jun 2022. Available from: URL: http://doi.org/10.1007/s00592-022-01909-9
Rights and permissions
About this article
Cite this article
Empagliflozin. Reactions Weekly 1924, 205 (2022). https://doi.org/10.1007/s40278-022-23558-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-23558-y